PRISM Mid-Day Movers: Robotic Medical Innovation and Disappointing Earnings Diverge Indices

NanoVibronix Surges 34% on Launch of AI-Enhanced Clinical Robotics Platform

NanoVibronix Inc. (NAOV) rallied 34.00% to lead the PRISM Emerging Healthcare Index after unveiling "ENvue Drive(TM)," a next-generation intelligent robotic platform in development for automating bedside feeding tube and vascular line placement. The AI-enhanced system integrates with the company's FDA-cleared electromagnetic guidance technology, aiming to improve precision and reduce staffing needs in critical care settings. With market opportunities surpassing $10 billion, the innovation targets high-frequency clinical workflows like nasoenteric feeding and PICC line placement, where procedural volume and workforce shortages present growing challenges.

Aethlon Medical Plunges 35% After Posting Wider-Than-Expected Fiscal Loss

Aethlon Medical Inc. (AEMD) sank 35.05%, dragging down the PRISM Emerging MedDevices Index, after reporting its fiscal 2025 results. The company disclosed a net loss of $13.4 million and a decline in revenue to $209,000 from $333,000 the previous year. Despite operating expenses falling 28% and early treatment progress in its Hemopurifier(R) trial for cancer patients in Australia, concerns about financial sustainability and regulatory timelines weighed on sentiment.

Other PRISM Mid-Day Movers:

• INmune Bio, Inc. (INMB) up 41.09%
• Helius Medical Technologies, Inc. (HSDT) down 32.66%
• Adial Pharmaceuticals, Inc. (ADIL) down 29.61%

The post PRISM Mid-Day Movers: Robotic Medical Innovation and Disappointing Earnings Diverge Indices appeared first on PRISM MarketView.

COMTEX_466715513/2927/2025-06-27T13:30:43